Literature DB >> 6797825

A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.

A T van Oosterom, T J Powles, E Hamersma, I E Smith, E Engelsman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6797825

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.

Authors:  A Ardizzoni; P Pronzato; L Canobbio; R Lionetto; R Rosso
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.

Authors:  D J Perez; T J Powles; J C Gazet; H T Ford; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.